期刊文献+

Functional characterization of SOX2 as an anticancer target 被引量:7

原文传递
导出
摘要 SOX2 is a well-characterized pluripotent factor that is essential for stem cell self-renewal,reprogramming,and homeostasis.The cellular levels of SOX2 are precisely regulated by a complicated network at the levels of transcription,post-transcription,and posttranslation.In many types of human cancer,SOX2 is dysregulated due to gene amplification and protein overexpression.SOX2 overexpression is associated with poor survival of cancer patients.Mechanistically,SOX2 promotes proliferation,survival,invasion/metastasis,cancer stemness,and drug resistance.SOX2 is,therefore,an attractive anticancer target.However,little progress has been made in the efforts to discover SOX2 inhibitors,largely due to undruggable nature of SOX2 as a transcription factor.In this review,we first briefly introduced SOX2 as a transcription factor,its domain structure,normal physiological functions,and its involvement in human cancers.We next discussed its role in embryonic development and stem cell-renewal.We then mainly focused on three aspects of SOX2:(a)the regulatory mechanisms of SOX2,including how SOX2 level is regulated,and how SOX2 cross-talks with multiple signaling pathways to control growth and survival;(b)the role of SOX2 in tumorigenesis and drug resistance;and(c)current drug discovery efforts on targeting SOX2,and the future perspectives to discover specific SOX2 inhibitors for effective cancer therapy.
出处 《Signal Transduction and Targeted Therapy》 SCIE CSCD 2020年第1期1304-1320,共17页 信号转导与靶向治疗(英文)
基金 supported by the National Key R&D Program of China(2016YFA0501800)(YS) the National Natural Science Foundation of China(81974429)(XX) the Chinese Scholarship Fund(201906320389)(SZ).
  • 相关文献

参考文献5

二级参考文献70

  • 1徐艳琼,李爱萍,陈瑞,周建伟.JWA在N-甲基-N’-硝基-N-亚硝基胍诱导的人支气管上皮细胞凋亡中的作用[J].中华劳动卫生职业病杂志,2006,24(4):205-208. 被引量:4
  • 2Thomson JA, ltskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282:1145-1147.
  • 3Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007; 318:1917-1920.
  • 4Rossant J. Stem cells and early lineage development. Cell 2008; 132:527-531.
  • 5Yamanaka S. A fresh look at iPS cells. Cell 2009; 137:13-17.
  • 6Boyer LA, Lee TI, Cole MF, et al. Core transcriptional reg-ulatory circuitry in human embryonic stem cells. Cell 2005; 122:947-956.
  • 7Dalton S. Signaling networks in human pluripotent stem cells. Curr Opin Cell Bio12013; 25:241-246.
  • 8Vallier L, Mendjan S, Brown S, et al. Activin/Nodal signal- ling maintains pluripotency by controlling Nanog expression. Development 2009; 136:1339-1349.
  • 9James D, Levine A J, Besser D, Hemmati-Brivanlou A. TGF- beta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development 2005; 132:1273-1282.
  • 10Armstrong L, Hughes O, Yung S, et al. The role of PI3K/ AKT, MAPK/ERK and NFkappabeta signalling in the main- tenance of human embryonic stem cell pluripotency and via- bility highlighted by transcriptional profiling and functional analysis. Hum Mol Genet 2006; 15:1894-1913.

共引文献23

同被引文献36

引证文献7

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部